Eris Lifesciences Limited — Others, 24-04-2025: ESOP/ESOS/ESPS

Eris Lifesciences has announced a board meeting to consider the allotment of 22,463 equity shares under the ESOP-2021 Scheme, resulting in an increase in paid-up share capital from ₹13,61,62,569 to ₹13,61,85,032. The allotment includes shares from various grant years: 7,595 shares at ₹557.24, 5,875 shares at ₹510.32, and 8,993 shares at ₹728.16 per share. This update indicates ongoing commitment to employee engagement through equity compensation. Investors may view this positively, as it suggests confidence in talent retention strategies, although potential dilution of existing shares could be a concern.